Skip to main content

Improved Genome Editing via Oviductal Nucleic Acids Delivery (i-GONAD): Protocol Steps and Additional Notes

  • Protocol
  • First Online:
Transgenesis

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR) technology has made it possible to produce genome-edited (GE) animals more easily and rapidly than before. In most cases, GE mice are produced by microinjection (MI) or by in vitro electroporation (EP) of CRISPR reagents into fertilized eggs (zygotes). Both of these approaches require ex vivo handling of isolated embryos and their subsequent transfer into another set of mice (called recipient or pseudopregnant mice). Such experiments are performed by highly skilled technicians (especially for MI). We recently developed a novel genome editing method, called “GONAD (Genome-editing via Oviductal Nucleic Acids Delivery),” which can completely eliminate the ex vivo handling of embryos. We also made improvements to the GONAD method, termed “improved-GONAD (i-GONAD).” The i-GONAD method involves injection of CRISPR reagents into the oviduct of an anesthetized pregnant female using a mouthpiece-controlled glass micropipette under a dissecting microscope, followed by EP of the entire oviduct allowing the CRISPR reagents to enter into the zygotes present inside the oviduct, in situ. After the i-GONAD procedure, the mouse recovered from anesthesia is allowed to continue the pregnancy to full term to deliver its pups. The i-GONAD method does not require pseudopregnant female animals for embryo transfer, unlike the methods relying on ex vivo handling of zygotes. Therefore, the i-GONAD method can reduce the number of animals used, compared to the traditional methods. In this chapter, we describe some newer technical tips about the i-GONAD method. Additionally, even though the detailed protocols of GONAD and i-GONAD have been published elsewhere (Gurumurthy et al., Curr Protoc Hum Genet 88:15.8.1–15.8.12, 2016 Nat Protoc 14:2452–2482, 2019), we provide all the protocol steps of i-GONAD in this chapter so that the reader can find most of the information, needed for performing i-GONAD experiments, in one place.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Harms DW et al (2014) Mouse genome editing using the CRISPR/Cas system. Curr Protoc Hum Genet 83:1571–15727

    Google Scholar 

  2. Cong L et al (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gurumurthy CB et al (2016) CRISPR/Cas9 and the paradigm shift in mouse genome manipulation technologies. In: Turksen K (ed) Genome editing. Springer Nature, Cham, pp 65–77

    Google Scholar 

  4. Wang W et al (2016) Delivery of Cas9 protein into mouse zygotes through a series of electroporation dramatically increases the efficiency of model creation. J Genet Genomics 43:319–327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hashimoto M, Yamashita Y, Takemoto T (2016) Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse. Dev Biol 418:1–9

    Article  CAS  PubMed  Google Scholar 

  6. Takahashi G et al (2015) GONAD: genome-editing via oviductal nucleic acids delivery system: a novel microinjection independent genome engineering method in mice. Sci Rep 5:11406

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ohtsuka M et al (2018) I-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases. Genome Biol 19:25

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sato M et al (2018) In vivo genome editing targeted towards the female reproductive system. Arch Pharm Res 41:898–910

    Article  CAS  PubMed  Google Scholar 

  9. Ohtsuka M, Sato M (2019) i-GONAD: a method for generating genome-edited animals without ex vivo handling of embryos. Develop Growth Differ 61:306–315

    Article  CAS  Google Scholar 

  10. Gurumurthy CB, Lloyd KCK (2019) Generating mouse models for biomedical research: technological advances. Dis Model Mech 12:dmm029462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Iwata S et al (2019) Simple and large-scale chromosomal engineering of mouse zygotes via in vitro and in vivo electroporation. Sci Rep 9:14713

    Article  PubMed  PubMed Central  Google Scholar 

  12. Iwata S et al (2021) An efficient i-GONAD method for creating and maintaining lethal mutant mice using an inversion balancer identified from the C3H/HeJJcl strain. G3 Genes Genomes Genet 11:jkab194

    Article  CAS  Google Scholar 

  13. Shang R, Zhang H, Bi P (2021) Generation of mouse conditional knockout alleles in one step using the i-GONAD method. Genome Res 31:121–130

    Article  PubMed  PubMed Central  Google Scholar 

  14. Quadros RM et al (2017) Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol 18:92

    Article  PubMed  PubMed Central  Google Scholar 

  15. Miura H, Quadros RM et al (2018) Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors. Nat Protoc 13:195–215

    Article  CAS  PubMed  Google Scholar 

  16. Gurumurthy CB et al (2016) GONAD: a novel CRISPR/Cas9 genome editing method that does not require ex vivo handling of embryos. Curr Protoc Hum Genet 88:15.8.1–15.8.12

    PubMed  Google Scholar 

  17. Gurumurthy CB et al (2019) Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD. Nat Protoc 14:2452–2482

    Article  CAS  PubMed  Google Scholar 

  18. Gurumurthy CB, Saunders TL, Ohtsuka M (2021) Designing and generating a mouse model: frequently asked questions. J Biomed Res 35:76–90

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the 2014 Tokai University School of Medicine Research Aid, Research and Study Project of Tokai University General Research Organization, 2016–2017 Tokai University School of Medicine Project Research, Grant-in-Aid for challenging Exploratory Research (15K14371) from JSPS, and Grant-in-Aid for Scientific Research (B) (21H02393) from JSPS to MO.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Masahiro Sato or Masato Ohtsuka .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Sato, M. et al. (2023). Improved Genome Editing via Oviductal Nucleic Acids Delivery (i-GONAD): Protocol Steps and Additional Notes. In: Saunders, T.L. (eds) Transgenesis. Methods in Molecular Biology, vol 2631. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2990-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2990-1_14

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2989-5

  • Online ISBN: 978-1-0716-2990-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics